| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
MUSCLE CELL BIOLOGY AND CELL MOTILITY
1Department of Pharmacology and 2Graduate Program in Biochemistry, Cell and Developmental Biology, Emory University, Atlanta, Georgia 30322
Submitted 12 February 2004 ; accepted in final form 8 April 2004
Skeletal muscle regeneration comprises several overlapping cellular processes, including inflammation and myogenesis. Prostaglandins (PGs) may regulate muscle regeneration, because they modulate inflammation and are involved in various stages of myogenesis in vitro. PG synthesis is catalyzed by different isoforms of cyclooxygenase (COX), which are inhibited by nonsteroidal anti-inflammatory drugs. Although experiments employing nonsteroidal anti-inflammatory drugs have implicated PGs in tissue repair, how PGs regulate muscle regeneration remains unclear, and the potentially distinct roles of different COX isoforms have not been investigated. To address these questions, a localized freeze injury was induced in the tibialis anterior muscles of mice chronically treated with either a COX-1- or COX-2-selective inhibitor (SC-560 and SC-236, respectively), starting before injury. The size of regenerating myofibers was analyzed at time points up to 5 wk after injury and found to be decreased by SC-236 and in COX-2–/– muscles, but unaffected by SC-560. In contrast, SC-236 had no effect on myofiber growth when administered starting 7 days after injury. The attenuation of myofiber growth by SC-236 treatment and in COX-2–/– muscles is associated with decreases in the number of myoblasts and intramuscular inflammatory cells at early times after injury. Together, these data suggest that COX-2-dependent PG synthesis is required during early stages of muscle regeneration and thus raise caution about the use of COX-2-selective inhibitors in patients with muscle injury or disease.
prostaglandins; nonsteroidal anti-inflammatory drugs; muscle growth; inflammation; satellite cells
This article has been cited by other articles:
|
|
 |
|
  U. R. Mikkelsen, H. Langberg, I. C. Helmark, D. Skovgaard, L. L. Andersen, M. Kjaer, and A. L. Mackey Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise J Appl Physiol, November 1, 2009; 107(5): 1600 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A Paoloni, C Milne, J Orchard, and B Hamilton Non-steroidal anti-inflammatory drugs in sports medicine: guidelines for practical but sensible use Br. J. Sports Med., October 1, 2009; 43(11): 863 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Paulsen, F. Lauritzen, M. L. Bayer, J. M. Kalhovde, I. Ugelstad, S. G. Owe, J. Hallen, L. H. Bergersen, and T. Raastad Subcellular movement and expression of HSP27, {alpha}B-crystallin, and HSP70 after two bouts of eccentric exercise in humans J Appl Physiol, August 1, 2009; 107(2): 570 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L Novak, W. Billich, S. M. Smith, K. B. Sukhija, T. J. McLoughlin, T. A. Hornberger, and T. J. Koh COX-2 inhibitor reduces skeletal muscle hypertrophy in mice Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1132 - R1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cheng, M.-H. Nguyen, G. Fantuzzi, and T. J. Koh Endogenous interferon-{gamma} is required for efficient skeletal muscle regeneration Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1183 - C1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Trappe, C. C. Carroll, B. Jemiolo, S. W. Trappe, S. Dossing, M. Kjaer, and S. P. Magnusson Cyclooxygenase mRNA expression in human patellar tendon at rest and after exercise Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R192 - R199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Mackey, M. Kjaer, S. Dandanell, K. H. Mikkelsen, L. Holm, S. Dossing, F. Kadi, S. O. Koskinen, C. H. Jensen, H. D. Schroder, et al. The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans J Appl Physiol, August 1, 2007; 103(2): 425 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Bamman Take two NSAIDs and call on your satellite cells in the morning J Appl Physiol, August 1, 2007; 103(2): 415 - 416. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Weinheimer, B. Jemiolo, C. C. Carroll, M. P. Harber, J. M. Haus, N. A. Burd, J. K. LeMoine, S. W. Trappe, and T. A. Trappe Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: implications for COX-inhibiting drugs and protein synthesis Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2241 - R2248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Tidball and M. Wehling-Henricks Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo J. Physiol., January 1, 2007; 578(1): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. McClung, J. M. Davis, and J. A. Carson Muscle: Ovarian hormone status and skeletal muscle inflammation during recovery from disuse in rats Exp Physiol, January 1, 2007; 92(1): 219 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shen, V. Prisk, Y. Li, W. Foster, and J. Huard Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2{alpha} J Appl Physiol, October 1, 2006; 101(4): 1215 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Homma, M. Iwasaki, G. D. Shelton, E. Engvall, J. C. Reed, and S. Takayama BAG3 Deficiency Results in Fulminant Myopathy and Early Lethality Am. J. Pathol., September 1, 2006; 169(3): 761 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Jansen and G. K. Pavlath Mannose receptor regulates myoblast motility and muscle growth J. Cell Biol., July 31, 2006; 174(3): 403 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. McClung, J. M. Davis, M. A. Wilson, E. C. Goldsmith, and J. A. Carson Estrogen status and skeletal muscle recovery from disuse atrophy J Appl Physiol, June 1, 2006; 100(6): 2012 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Summan, G. L. Warren, R. R. Mercer, R. Chapman, T. Hulderman, N. Van Rooijen, and P. P. Simeonova Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1488 - R1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Bondesen, S. T. Mills, and G. K. Pavlath The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1651 - C1659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Dupouy, P. J. Ferre, E. Uro-Coste, and H. P. Lefebvre Time course of COX-1 and COX-2 expression during ischemia-reperfusion in rat skeletal muscle J Appl Physiol, January 1, 2006; 100(1): 233 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Tidball Inflammatory processes in muscle injury and repair Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R345 - R353. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
